From retail rocket to reality check
Fundrise VCX came out swinging. The closed-end fund gave investors a shiny new way to chase private-market heavyweights like OpenAI, SpaceX, Anthropic, and Databricks, and the stock promptly behaved like it had just discovered gravity was optional. Shares rocketed to absurd levels, at one point trading nearly 1,900% above the fund’s roughly $19 NAV.
Then Citron showed up
Enter the short report, stage left. Citron Research blasted the fund’s valuation, pointing to the huge premium over NAV and raising old-school investor hygiene questions about the sponsor’s regulatory history. That was enough to flip the vibe from “pre-IPO access for the masses” to “wait, are we paying a hedge-fund-sized markup for a wrapper?”
Why investors should care
This isn’t just a dramatic chart. When a fund trades at 5x to 6x its underlying asset value, you’re not just betting on the private companies inside — you’re also betting that everyone else keeps willing to overpay for the ticket. If that enthusiasm fades, the premium can compress faster than a bad startup deck at a VC partner meeting.
The bigger picture
Sure, the fund still has the allure of possible future liquidity events for holdings like SpaceX. But the whole episode is a reminder that in private-market land, the wrapper matters almost as much as the assets. Big picture: when sentiment is doing the heavy lifting, a short report can turn a rocket ship into a very expensive sobriety check.